Famotidine Dosing for Creatinine Clearance <60 mL/min
For patients with creatinine clearance less than 60 mL/min, reduce famotidine to a maximum of 20 mg once daily (or 40 mg every other day) for CrCl 30-60 mL/min, and 20 mg every other day for CrCl <30 mL/min. 1
Dosing Algorithm by Renal Function
Moderate Renal Impairment (CrCl 30-60 mL/min)
- Maximum dose: 20 mg once daily OR 40 mg every other day 1
- Use the lowest effective dose for the indication
- All standard indications (active ulcer, GERD, erosive esophagitis) follow this maximum dosing
Severe Renal Impairment (CrCl <30 mL/min)
- Maximum dose: 20 mg every other day 1
- Alternative regimen: 10 mg once daily (requires different formulation than 20/40 mg tablets)
- This applies to all indications except pathological hypersecretory conditions
Pathological Hypersecretory Conditions
- Avoid use in patients with CrCl <30 mL/min 1
- The high doses required (up to 160 mg every 6 hours) exceed what has been safely evaluated in renal impairment
- Risk of adverse reactions is unknown in this population
Pharmacokinetic Rationale
The dosing adjustments are necessary because famotidine elimination is predominantly renal (65-70% unchanged in urine) 1. The drug undergoes both glomerular filtration and active tubular secretion 2, 3.
Key pharmacokinetic changes in renal impairment:
- Systemic exposure (AUC) increases at least 2-fold with CrCl 30-60 mL/min 1
- AUC increases at least 5-fold with CrCl <30 mL/min 1
- Half-life extends from 2.5-3.5 hours (normal) to 4.7 hours (moderate impairment) to 12 hours (severe impairment) 2
Critical Pitfalls to Avoid
Do not use standard doses in renal impairment. The 5-fold increase in drug exposure with severe renal dysfunction creates significant risk for accumulation and adverse effects, even though famotidine is generally well-tolerated 2, 4.
Recognize that tubular secretion deteriorates faster than glomerular filtration in progressive renal disease 4. This means renal clearance of famotidine declines disproportionately as kidney function worsens.
For doses requiring 10 mg or alternate-day 20 mg regimens, you cannot use the 20 mg or 40 mg tablet strengths—switch to oral suspension or other formulations 1.
Dialysis Considerations
Famotidine is not significantly removed by hemodialysis, peritoneal dialysis, or hemofiltration 3, 5. Do not give supplemental doses after dialysis sessions. Maintain the dosing schedule appropriate for the patient's residual renal function.